Back Page

Print
Email
Share

“I was always interested in how cells multiply, how they respond to signals and how this impacts human disease such as cancer. How does a cell know when to divide or rest? How does a cell know whether to turn into an insulin-producing pancreatic cell or, a brain cell that makes neurotransmitters? Many of the decisions that cells make are tightly linked to human disease and so understanding these processes will probably lead to new cures. All of this has been intertwined with my research on stem cells and how they can be used to develop new therapies and diagnostics.

“I can’t imagine myself doing anything else. There’s so much more to do, and as time goes on the field is gaining more and more momentum. We are now approaching the era of stem cell-based therapeutics—this is going to have a massive impact on the way we treat diseases and injury. Ten years ago it was a pipe dream, but now we’re approaching an era where stem cells will be the platform for curing a wide range of human diseases including diabetes, cardiovascular disease and neurological disorders.”

—Stephen Dalton, on how he became interested in stem cell biology and how it can be used in molecular medicine.

Stephen Dalton

Professor, molecular cell biology, Franklin College of Arts and Sciences

Director, Center for Molecular Medicine

BSc, biochemistry and cell biology, Flinders University of South Australia

BSc Honors, First Class, biochemistry, Flinders University School of Medicine

Ph.D., biochemistry and molecular biology, University of Adelaide, South Australia

Georgia Cancer Coalition Distinguished Scientist/Clinician Award, 2003

Georgia Research Alliance Chair and Eminent Scholar in Molecular Cell Biology, 2003 Award for Outstanding Service to UGA and to the State of Georgia, presented by   UGA President Michael F. Adams, 2004